Please assess the completion status of the following clinical trial:

Trial Title: Predictive Value of Bone Turnover Markers During Discontinuation With Alendronate

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Postmenopausal women (postmenopausal for at least two years)~* Men above 50 years~* Treatment for at least five years with alendronate~* BMD T-score total hip \> -2.5~* BMD T-score lumbar spine (L1-L4) \> -4~Exclusion Criteria:~* Any low-energy fracture within the previous five years during alendronate treatment (not including fingers, toes, or skull)~* Low-energy vertebral fracture at any time~* Low-energy hip fracture at any time~* Ongoing treatment with glucocorticoids~* Metabolic bone disease~* Hormone replacement therapy~* Cancer~* Other conditions affecting bone metabolism

- Gender: ALL
- Minimum Age: 50 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).